A small-molecule dual-inhibitor of CXCR1 and CXCR2, designed to inactivate immunosuppressive myeloid cells and enhance the immune system's ability to eliminate cancer cells.

An active metabolite of tramadol that provides pain relief without requiring metabolic activation, eliminating common drug-drug and metabolism issues associated with tramadol.